Sradha Kotwal's Publications

About Sradha Kotwal's Publications

Program Head, Renal and Metabolic Division

  • Mass Spectrometric Measurements of 11-Deoxycortisol, Androstenedione and Dehydroepiandrosterone Are Superior to Cortisol to Assess Selectivity of Non-Stimulated Adrenal Vein Sampling

    Clinical Endocrinology Date published:

  • Quality of care for people with chronic kidney disease: a systematic review and meta-analysis

    BMJ Open Date published:

  • Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management

    Heart, Lung and Circulation Date published:

  • The epidemiology of haemodialysis catheter infections in Australia, 2016-20: a prospective cohort study

    Medical Journal of Australia Date published:

  • Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

    Diabetes, Obesity and Metabolism Date published:

  • Albuminuria, Kidney Function and Heart Failure Risk in Type 2 Diabetes: Participant-level pooled analysis from CANVAS Program and CREDENCE trial

    Journal of Cardiac Failure Date published:

  • Changes in Dialysis Practice Patterns in Australia and New Zealand During the COVID -19 Pandemic Period

    Nephrology Date published:

  • Prophylactic Antibiotics Before Insertion of Tunneled Hemodialysis Catheters: A Nationwide Cohort Study

    Kidney Medicine Date published:

  • Glomerular disease registry and biobank: design and baseline results

    Internal Medicine Journal Date published:

  • Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset

    The Lancet Regional Health - Western Pacific Date published:

  • Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD

    Kidney International Reports Date published:

  • Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial

    Nephrology Dialysis Transplantation Date published:

  • Effects of Semaglutide on CKD in Patients With Type 2 Diabetes

    Kidney International Reports Date published:

  • Risk factors associated with 30-day mortality following COVID -19 infection in patients receiving kidney replacement therapy in Australia and New Zealand

    Internal Medicine Journal Date published:

  • Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial

    Diabetes, Obesity and Metabolism Date published: